Genitourinary Radiology: Page 9

Fracture risk tool validated in men with prostate cancer

By Will Morton

Researchers in Canada have for the first time validated the Fracture Risk Assessment Tool (FRAX) in men with prostate cancer, according to a study published February 20 in the Journal of Bone and Mineral Research

February 28, 2023

Black patients experience higher rates of dialysis graft failures

By Will Morton

Black patients are more likely than other races to experience premature arteriovenous graft failure in the treatment of advanced kidney failure, according to a study published February 21 in Radiology.

February 21, 2023

CEUS better than MRI for diagnosing liver, kidney tumors

By AuntMinnie.com staff writers

Contrast-enhanced ultrasound (CEUS) is better than MRI for diagnosing particular liver and kidney tumors, according to studies being highlighted by the International Contrast Ultrasound Society meeting.

February 20, 2023

Are hospitals disclosing prostate cancer service costs?

By Kate Madden Yee

Hospitals aren't necessarily disclosing prostate cancer service costs, despite a 2021 mandate issued by the U.S. Centers for Medicare and Medicaid Services (CMS), a January 30 study published in Prostate Cancer Prostatic Disease has found.

February 1, 2023

3D printing method uses MRI to build pediatric urology models

By Amerigo Allegretto

Researchers from Children's Hospital of Philadelphia are highlighting a genitourinary 3D modeling and printing process using post-contrast MRI that they believe can help with pediatric urologic surgical planning.

January 18, 2023

MRI guidance beats CT for prostate cancer stereotactic body radiotherapy

By Kate Madden Yee

MRI-guided stereotactic body radiotherapy outperforms CT guidance when it comes to reducing toxic effects of the treatment, according to a study published January 12 in JAMA Oncology.

January 12, 2023

Spine x-rays recommended in prostate cancer patients

By Will Morton

Spinal x-rays should be considered to determine the true risk of vertebral fractures in men with prostate cancer prior to androgen deprivation therapy, according to a study published in the February issue of the Journal of Bone Oncology.

January 8, 2023

PSMA-PET shows value in primary staging of prostate cancer

By Will Morton

Prostate-specific membrane antigen (PSMA) PET/CT imaging can reveal metastatic bone cancer lesions in prostate cancer patients that may be undetected by conventional bone scintigraphy, according to a group in the Netherlands.

January 5, 2023

MRI-targeted prostate biopsy protocol halves overdiagnosis

By Kate Madden Yee

A prostate cancer biopsy protocol based on targeted MRI rather than systemic ultrasound shows promise for reducing overdiagnosis by half, according to study results published December 8 in the New England Journal of Medicine.

December 7, 2022

Does contrast-enhanced CT boost kids' acute kidney injury risk?

By Kate Madden Yee

Does contrast-enhanced CT boost the incidence of acute kidney injury in children? It doesn't seem so, according to a study published December 6 in Radiology.

December 7, 2022

Can AI improve diagnostic accuracy for prostate MRI?

By Erik L. Ridley

Monday, November 28 | 1:30 p.m.-2:30 p.m. | M6-SSGU03-5 | Room S406BPreliminary results from a large Dutch study suggest that an artificial intelligence (AI) algorithm could help improve diagnostic accuracy in interpreting prostate MRI exams.

November 13, 2022

MRI after PSA testing is more cost-effective than standard protocol

By Kate Madden Yee

Prostate cancer screening that combines prostate-specific antigen (PSA) testing followed by an MRI is more cost-effective than the traditional pathway of PSA to standard biopsy, according to a study published November 10 in JAMA Oncology.

November 10, 2022

Previous Page

Page 9 of 93

Next Page